Public release date: 16-Oct-2012 [ | E-mail | Share ] <\/p>\n
Contact: Shelly Leachman shelly.leachman@ia.ucsb.edu<\/a> 805-893-8726 University of California - Santa Barbara<\/p>\n (Santa Barbara, Calif.) By growing new retinal cells to replace those that have malfunctioned, scientists hope to one day create and fuse entire layers of fresh cells a synthetic patch akin to a contact lens as a treatment for age-related macular degeneration, the top cause of visual impairment among people over 60. <\/p>\n Such is the goal of an elite research team at UC Santa Barbara, which aims to advance the novel therapy out of the lab and into the clinic by way of regenerative bioengineering. With stem cells also showing great promise for diabetic retinopathy, the same group is taking a similar approach to this condition the leading cause of blindness in younger adults. <\/p>\n Based at UCSB's Center for Stem Cell Biology and Engineering, the two projects are being pursued in tandem, in a new, five-year endeavor funded by a $5-million gift from philanthropist Bill Bowes, founder of biotechnology giant Amgen. With the development of cellular therapies as its goal, the Garland Initiative for Vision named for Bowes' mother, who was a physician and Santa Barbara native will position the campus to propel its ocular innovations toward clinical trials. <\/p>\n \"UC Santa Barbara is honored by the visionary and generous philanthropy of Bill and Ute Bowes in establishing the Garland Initiative. We are deeply grateful for their longstanding leadership and dedication to advance critical research in ocular diseases,\" said Chancellor Henry T. Yang. \"This gift expands the impact of the Bowes' earlier inspirational gift to establish the Ruth Garland Professor and Co-Director of the Center for Stem Cell Biology and Engineering, and will fuel new discoveries and further strengthen the outstanding work of our faculty conducting interdisciplinary research in bioengineering and biomedicine. <\/p>\n Asked what inspires him to give, Bowes, Amgen's first chairman and the still-active founding partner of Silicon Valley-based U.S. Venture Partners, said, \"For me, philanthropy is the best use of resources, by far. I've come to respect UC Santa Barbara as a very important technological institution. My firm has used Santa Barbara technologies to start companies, and that has enabled me to get a pretty good look at what's going on down there. My respect level has been going up and up and up over the years. That's all it takes. <\/p>\n \"I put UC Santa Barbara in a small cadre of institutions that I have respect for and work with and support that includes Caltech, UCSF, Stanford, and Harvard,\" Bowes added. \"The people at UC Santa Barbara and the technology there are ripe for a program that makes some real accomplishments in the vision field.\" <\/p>\n A stem cell dream team of renowned researchers all directors of the UC Santa Barbara stem cell center will lead the Bowes-funded project. They include Dennis Clegg, a professor of molecular, cellular, and developmental biology, and co-principal investigator of the California Project to Cure Blindness; Neuroscience Research Institute research biologist Peter Coffey, director of the London Project to Cure Blindness; James Thomson, professor of molecular, cellular, and developmental biology at UCSB, and director of Regenerative Biology at the University of Wisconsin's Morgridge Institute for Research; and H. Tom Soh, professor of mechanical engineering and of materials, associate director of the California NanoSystems Institute, and a 2010 Guggenheim Fellow in engineering. <\/p>\n The Garland Initiative will tackle age-related macular degeneration and diabetic retinopathy with biology and engineering two of UCSB's core scientific strengths. <\/p>\n<\/p>\n Read this article: Public release date: 16-Oct-2012 [ | E-mail | Share ] Contact: Shelly Leachman shelly.leachman@ia.ucsb.edu<\/a> 805-893-8726 University of California - Santa Barbara (Santa Barbara, Calif.) By growing new retinal cells to replace those that have malfunctioned, scientists hope to one day create and fuse entire layers of fresh cells a synthetic patch akin to a contact lens as a treatment for age-related macular degeneration, the top cause of visual impairment among people over 60. Continue reading
\nEnvisioning novel approaches for eye disease: 'The new medicine' at UC Santa Barbara<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"